Ramya Thota

Measuring ovarian toxicity in clinical trials: an American Society of Clinical Oncology research statement.

Caroline Schenkel, L. Amiri-Kordestani, K. Phillips, 2023, The Lancet. Oncology.

Sunitinib in Patients With Breast Cancer With FGFR1 or FGFR2 Amplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.

R. Schilsky, C. Calfa, K. Gogineni, 2024, JCO precision oncology.

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma.

T. Crocenzi, Tae-You Kim, Y. Hotko, 2024, Annals of oncology : official journal of the European Society for Medical Oncology.